CD4+ T cells are essential for antitumor immunity, whereby they act as the driving force of the cancer immunity cycle by assisting the priming and clonal expansion of CD8+ T cells in the lymph nodes, promoting their migration into the peripheral blood circulation and infiltration into the tumor microenvironment []. This evidence concerns the gene CD8A and cancer.